Clinic
Mayo Clinic Health System-Southwest Wisconsin Region, INC.
Mayo Clinic Health System-Southwest Wisconsin Region, INC. was paid $8.76M by Medicaid between Jan 2018 and Dec 2024, across 201 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 23% of everything it billed.
33Billing provider infoMAYO CLINIC HEALTH SYSTEM-SOUTHWEST WISCONSIN REGION, INC.
LACROSSE, WI 54601
LACROSSE, WI 54601
33aNPI1629056049assigned 01/05/2006
33bProvider typeMulti-Specialty Clinic/Center
28Total paid$8.76M
24GClaims363,613
24DCodes billed201
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Multi-Specialty Clinic/Center providers in Wisconsin
Rank by total paid#8 of 40
Median peer was paid$333K
This provider vs. median26×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official BORTNEM, MARK controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 62,961 | $1.17M | |
| 2019 | 53,388 | $1.29M | |
| 2020 | 43,069 | $1.02M | |
| 2021 | 68,988 | $1.51M | |
| 2022 | 51,761 | $1.32M | |
| 2023 | 50,311 | $1.35M | |
| 2024incomplete | 33,135 | $1.10M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 23% | 56,261 | 50,330 | $2.00M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 19% | 64,293 | 58,149 | $1.62M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 12% | 23,400 | 21,557 | $1.02M |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 6.2% | 11,761 | 7,180 | $542K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 5.2% | 12,896 | 12,325 | $454K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2.9% | 6,769 | 6,292 | $256K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 2.9% | 7,472 | 5,480 | $251K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 2.8% | 9,071 | 8,423 | $246K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 2.3% | 3,903 | 3,434 | $202K |
| 92015 | Determination of refractive state | 1.7% | 19,451 | 18,508 | $153K |
| 90837 | Psychotherapy session, about an hourPsychotherapy, 53 minutes with patient | 1.3% | 1,938 | 1,091 | $116K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.3% | 9,917 | 8,993 | $114K |
189 more codes
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1.2% | 1,778 | $103K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 1.1% | 2,485 | $95K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 17,530 | $86K |
| 67028 | Intravitreal injection of a pharmacologic agent | <1% | 1,310 | $84K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 2,523 | $75K |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 1,535 | $66K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 8,420 | $55K |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | <1% | 1,128 | $52K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 910 | $51K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 771 | $43K |
| 80061 | Lipid panel | <1% | 3,648 | $41K |
| 87660 | <1% | 2,452 | $39K | |
| 87510 | <1% | 2,445 | $39K | |
| 87480 | <1% | 2,458 | $39K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 5,265 | $36K |
| 87631 | <1% | 681 | $36K | |
| 90686 | <1% | 4,272 | $35K | |
| 80053 | Comprehensive metabolic panel | <1% | 4,127 | $34K |
| 0002A | <1% | 1,012 | $32K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 759 | $30K |
| 90847 | Family psychotherapy with the patient present, 50 minutes | <1% | 519 | $27K |
| 0001A | <1% | 1,010 | $27K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 3,490 | $27K |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 1,673 | $25K |
| 64615 | <1% | 552 | $23K | |
| 92340 | Fitting of spectacles, except for aphakia; monofocal | <1% | 1,019 | $21K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 589 | $21K |
| 92134 | <1% | 1,763 | $21K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,813 | $19K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 328 | $18K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 658 | $18K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 335 | $18K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 697 | $17K |
| 20611 | <1% | 509 | $17K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 882 | $17K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 688 | $16K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 397 | $16K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,019 | $16K |
| 71045 | Radiologic examination, chest; single view | <1% | 4,057 | $15K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 188 | $15K |
| 92341 | <1% | 598 | $14K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 352 | $14K |
| 93000 | <1% | 932 | $14K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 1,598 | $14K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 190 | $12K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 251 | $12K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 14 | $11K |
| 85027 | <1% | 1,972 | $11K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 857 | $10K |
| 99310 | Prolong nursin fac eval 15m | <1% | 757 | $10K |
| 81025 | <1% | 1,449 | $10K | |
| 92567 | <1% | 636 | $8K | |
| 20610 | <1% | 295 | $7K | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 737 | $7K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 152 | $7K |
| 81001 | <1% | 2,418 | $7K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 252 | $7K |
| 0004A | <1% | 168 | $6K | |
| 88307 | <1% | 86 | $5K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 134 | $5K |
| 99442 | <1% | 275 | $5K | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 118 | $5K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 153 | $5K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 187 | $5K |
| 91322 | <1% | 74 | $4K | |
| 86140 | <1% | 1,009 | $4K | |
| 81003 | <1% | 2,263 | $4K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 31 | $4K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 303 | $4K |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 2,018 | $4K |
| 98926 | <1% | 282 | $3K | |
| 0071A | <1% | 136 | $3K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 99 | $3K |
| 11721 | <1% | 306 | $3K | |
| 73630 | <1% | 209 | $3K | |
| 99443 | <1% | 57 | $2K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 42 | $2K |
| 99223 | Prolong inpt eval add15 m | <1% | 69 | $2K |
| 85018 | <1% | 914 | $2K | |
| 88142 | <1% | 104 | $2K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,039 | $2K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 59 | $2K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 524 | $2K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 24 | $2K |
| 99243 | <1% | 41 | $2K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 116 | $2K |
| 94060 | <1% | 98 | $2K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 210 | $2K |
| 0072A | <1% | 99 | $2K | |
| 0124A | <1% | 46 | $2K | |
| 3008F | <1% | 206 | $2K | |
| 98927 | <1% | 63 | $2K | |
| 90656 | <1% | 84 | $1K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 13 | $1K |
| 99460 | <1% | 14 | $1K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 14 | $1K |
| 94729 | <1% | 92 | $1K | |
| 90836 | <1% | 14 | $1K | |
| 0064A | <1% | 31 | $1K | |
| 99188 | <1% | 83 | $1K | |
| 11056 | <1% | 46 | $924.92 | |
| 62323 | <1% | 15 | $903.02 | |
| 88141 | <1% | 55 | $865.51 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 315 | $842.83 |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 13 | $826.29 |
| 73610 | <1% | 72 | $752.09 | |
| 99356 | <1% | 51 | $750.19 | |
| 95886 | <1% | 29 | $749.48 | |
| 90670 | <1% | 230 | $719.57 | |
| 0031A | <1% | 26 | $684.20 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 242 | $681.92 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 239 | $681.92 |
| 94726 | <1% | 51 | $661.78 | |
| 82947 | <1% | 253 | $655.74 | |
| 99441 | <1% | 73 | $601.08 | |
| 64493 | <1% | 22 | $563.91 | |
| 0012A | <1% | 41 | $522.82 | |
| 88342 | <1% | 33 | $520.50 | |
| 76942 | <1% | 12 | $515.03 | |
| 95251 | <1% | 37 | $513.41 | |
| 76642 | <1% | 29 | $510.67 | |
| 90698 | <1% | 192 | $506.11 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 41 | $470.28 |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 14 | $440.76 |
| 95800 | <1% | 25 | $365.15 | |
| 0011A | <1% | 47 | $357.30 | |
| 90685 | <1% | 110 | $344.24 | |
| 99462 | <1% | 14 | $340.34 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 110 | $310.90 |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 13 | $300.43 |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 25 | $276.57 |
| 72100 | <1% | 18 | $258.95 | |
| 73030 | <1% | 14 | $238.22 | |
| 73502 | <1% | 15 | $231.39 | |
| 64494 | <1% | 20 | $206.19 | |
| 96164 | <1% | 42 | $185.88 | |
| 86780 | <1% | 92 | $176.11 | |
| 96165 | <1% | 40 | $172.17 | |
| 92133 | <1% | 16 | $166.57 | |
| 90785 | <1% | 13 | $164.64 | |
| 99173 | <1% | 19 | $152.00 | |
| 90680 | <1% | 40 | $122.47 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 66 | $82.92 |
| 90651 | <1% | 25 | $78.68 | |
| 74018 | <1% | 14 | $71.07 | |
| 86850 | <1% | 63 | $57.31 | |
| 84460 | <1% | 29 | $46.99 | |
| 90633 | <1% | 25 | $46.51 | |
| 93294 | <1% | 13 | $44.15 | |
| 82570 | <1% | 14 | $43.26 | |
| 85652 | <1% | 13 | $36.50 | |
| 87077 | <1% | 87 | $35.88 | |
| 0764T | <1% | 129 | $24.00 | |
| 99451 | <1% | 16 | $21.48 | |
| 94762 | <1% | 53 | $4.85 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | <1% | 1,480 | $1.31 |
| 91300 | 0% | 2,339 | $0.00 | |
| 3078F | 0% | 2,294 | $0.00 | |
| 85610 | 0% | 107 | $0.00 | |
| X5622 | 0% | 358 | $0.00 | |
| 87186 | 0% | 42 | $0.00 | |
| 0502F | 0% | 15 | $0.00 | |
| 86787 | 0% | 27 | $0.00 | |
| 87653 | 0% | 36 | $0.00 | |
| 84439 | 0% | 16 | $0.00 | |
| 91312 | 0% | 46 | $0.00 | |
| 83540 | 0% | 14 | $0.00 | |
| 99358 | Prolong nursin fac eval 15m | 0% | 32 | $0.00 |
| G9717 | Documentation stating the patient has had a diagnosis of bipolar disorder | 0% | 4,548 | $0.00 |
| 3074F | 0% | 3,166 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 97 | $0.00 |
| 91303 | 0% | 26 | $0.00 | |
| 3079F | 0% | 223 | $0.00 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 0% | 79 | $0.00 |
| G8432 | Depression screening not documented, reason not given | 0% | 142 | $0.00 |
| 87070 | 0% | 278 | $0.00 | |
| 86803 | 0% | 59 | $0.00 | |
| 3075F | 0% | 36 | $0.00 | |
| 82728 | 0% | 52 | $0.00 | |
| 91307 | 0% | 296 | $0.00 | |
| V5008 | Hearing screening | 0% | 19 | $0.00 |
| 91306 | 0% | 31 | $0.00 | |
| 87340 | 0% | 67 | $0.00 | |
| 82043 | 0% | 53 | $0.00 | |
| 91301 | 0% | 35 | $0.00 | |
| 82607 | 0% | 12 | $0.00 | |
| 86762 | 0% | 15 | $0.00 | |
| 83550 | 0% | 14 | $0.00 | |
| 82950 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBORTNEM, MARK (CHIEF FINANCIAL OFFICER)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.